GlobeImmune and NantCell work to advance tumor research in cancer trials

GlobeImmune and NantCell work to advance tumor research in cancer trials

LOUISVILLE -- GlobeImmune, Inc. today announced a number of developments in its clinical programs and licensing and manufacturing activities. The company previously announced that... Read More

Monday August 28, 2017 0 comments Tags: Louisville, GlobeImmune, NantCell, Jeffrey Dekker, Patrick Soon-Shiong